Risk factors for drug-resistant tuberculosis patients in Lithuania, 2002-2008

European Respiratory Journal

Volumn 39, Issue 5, 2012, Pages 1266-1269

  Balabanova, Yanina ^a,b   Radiulyte, Birute ^c   Davidaviciene, Edita ^c   Hooper, Richard ^a   Ignatyeva, Olga ^b   Nikolayevskyy, Vladyslav ^a   Drobniewski, Francis A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Samara Oblast Tuberculosis Dispensary   (Russian Federation)

^c University Hospital   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGE DISTRIBUTION; ALCOHOL ABUSE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG ABUSE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GENETIC PROCEDURES; GENOTYPE; HUMAN; LETTER; LITHUANIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETREATMENT; RISK FACTOR; SEX DIFFERENCE; SOCIAL STATUS; SPOLIGOTYPING; TREND STUDY; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; LITHUANIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84860487230     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00133911     Document Type: Letter

References (10)

1. European Center for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance in Europe 2009. Stockholm, European Centre for Disease Prevention and Control, 2011.
2. Lithuanian National Tuberculosis Register. Annual Report 2011. Vilnius, Lithuanian National Tuberculosis Control Programme, 2011.
3. Bakonyte D, Baranauskaite A, Cicenaite J, et al. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother 2003; 47: 2009-2011. (Pubitemid 36637834)
4. Kliiman K, Altraja A. Predictors of extensively drug-resistant pulmonary tuberculosis. Ann Intern Med 2009; 150: 766-775.
5. Leimane V, Dravniece G, Riekstina V, et al. Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur Respir J 2010; 36: 584-593.
6. Podewils LJ, Holtz T, Riekstina V, et al. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiol Infect 2011; 139: 113-120.
7. Drobniewski F, Balabanova Y, Nikolayevsky V, et al. Drugresistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005; 293: 2726-2731. (Pubitemid 40965084)
8. Mokrousov I, Otten T, Zozio T, et al. At Baltic crossroads: a molecular snapshot of Mycobacterium tuberculosis population diversity in Kaliningrad, Russia. FEMS Immunol Med Microbiol 2009; 55: 13-22.
9. Kruuner A, Hoffner SE, Sillastu H, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001; 39: 3339-3345. (Pubitemid 32830336)
10. Tracevska T, Jansone I, Baumanis V, et al. Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2003; 7: 1097-1103. (Pubitemid 37376962)